Vimentin, in particular, was substantially expressed in activated hepatocyte stellate cells (HSCs).18,19 As a result, inhibiting HSC cell growth and inhibiting the IL-6/STAT3 pathway could be a promising technique for inhibiting cancer cell progression.13,20,21. This evidence concerns the gene VIM and cancer.